• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Relay Therapeutics Inc (NQ: RLAY )

    6.105 -0.145 (-2.32%)
    Streaming Delayed Price Updated: 1:05 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Relay Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
    Via Benzinga
    5 Analysts Have This to Say About Relay Therapeutics
    Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings within the last quarter: 
    Via Benzinga
    Expert Ratings for Relay Therapeutics
    Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings: 
    Via Benzinga
    4 Analysts Have This to Say About Relay Therapeutics
    Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings: 
    Via Benzinga
    Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Participate in Two Upcoming Investor Conferences
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
    Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
    Via Benzinga
    Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For November 3, 2022
    Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
    Via Benzinga
    Relay Therapeutics's Earnings Outlook
    Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Relay... 
    Via Benzinga
    Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022
    Upgrades 
    Via Benzinga
    7 Unknown Biotech Stocks That Could Rocket in 2023
    Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline. 
    Via InvestorPlace
    Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
    Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... 
    Via Benzinga
    Tesla, Meta, NVIDIA And Other Big Losers From Tuesday
    U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
      
    Via Benzinga
    Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
    Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
    Via Benzinga
    Why Relay Therapeutics Shares Are Getting Hammered
    Relay Therapeutics Inc (NASDAQ: RLAY) shares are trading lower by 11.33% to $25.54 Tuesday morning after the company priced a roughly 11.32 million share public offering of common stock at $26.50 per... 
    Via Benzinga
    Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
    Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. 
    Via Benzinga
    Relay Therapeutics, Rent the Runway And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
    U.S. stock futures traded higher this morning ahead of the much-awaited inflation data for August. Here are some big stocks moving lower in today’s pre-market trading session. 
    Via Benzinga
    Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket
    Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average... 
    Via Benzinga
    Dow, Nasdaq Futures Move Higher; All Eyes On Inflation Data
    Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording gains on Monday. The Dow Jones surged around 230 points, while the Nasdaq Composite jumped more... 
    Via Benzinga
    Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008
    From Foundation Medicine
    Via Business Wire
    AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
    Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
    Via Benzinga
    Relay Therapeutics Shares Jump After Interim Data From Bile Duct Cancer Drug Ahead Of ESMO Presentation
    Via Benzinga
    Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
    Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022
      
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.